(Q43152513)

14 November 2017

title

Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia (English)

1 reference

14 November 2017

0 references

Nakarin Sansanayudh

1

1 reference

14 November 2017

Supakit Wongwiwatthananukit

series ordinal

2

1 reference

14 November 2017

Pawat Putwai

series ordinal

3

1 reference

14 November 2017

Rawadee Dhumma-Upakorn

series ordinal

4

1 reference

14 November 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

Annals of Pharmacotherapy

14 November 2017

published in

1 reference

14 November 2017

volume

44

1 reference

14 November 2017

issue

3

1 reference

14 November 2017

page(s)

415-423

1 reference

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

14 November 2017

cites work

1 reference

Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastat

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?

21 January 2018

1 reference

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA)

21 January 2018

1 reference

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

21 January 2018

1 reference

The Helsinki Heart Study: central findings and clinical implications

21 January 2018

1 reference

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin

21 January 2018

1 reference

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

21 January 2018

1 reference

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.

21 January 2018

1 reference

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia

21 January 2018

1 reference

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis pr

21 January 2018

1 reference

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-dens

21 January 2018

1 reference

Pitavastatin: efficacy and safety in intensive lipid lowering

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes

21 January 2018

1 reference

Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell

21 January 2018

1 reference

Efficacy and safety of rosuvastatin every other day compared with once daily in patients with hypercholesterolemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M522

1 reference

14 November 2017

1 reference